VEGF Inhibition

Baseline hypertension, ASIs affect hypertension, survival during VEGF inhibitor therapy

Baseline hypertension, ASIs affect hypertension, survival during VEGF inhibitor therapy

By

Baseline hypertension and BMI can affect worsening hypertension among patients administered vascular endothelial growth factor signaling pathway inhibitors, according to research presented at the 2014 ASCO Annual Meeting.

Vascular targeting in ovarian cancer: Therapeutic advances may improve the prognosis

Targeting tumor vasculature by inhibiting angiogenesis is a promising approach for women with advanced ovarian cancer, and clinical trials should designed to ensure that novel agents are evaluated rapidly

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs